Follow the 인콘 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Business Services sector, 인콘 has published 35 insider filings. The latest transaction was disclosed on 3 July 2026 (Purchase). Among the most active insiders: 케이바이오랩스. All data is free.
35
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
23 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.